Expression of PD-L1 and BCG immunotherapy in non-muscle invasive bladder cancer

被引：2
|
作者：
Heo, Jun Hyeok
Jin, Hyun A.
Kang, You Hyun
Kim, Ki Hong
Hong, Sung Joon
Han, Kyung Seok
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.TME16-A16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A16
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Does PD-L1 Expression in Non-Muscle-Invasive Bladder Cancer Correlate with Recurrence and Progression?
    Gajzer, David
    Becerra, Maria
    Escobar, Maria Velasquez
    Kwon, Deukwoo
    Ritch, Chad
    Kryvenko, Oleksandr
    Jorda, Merce
    LABORATORY INVESTIGATION, 2019, 99
  • [22] Immunotherapy of High Risk Non-Muscle Invasive Bladder Cancer
    Ahdoot, Michael
    Theodorescu, Dan
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (11) : 1345 - 1352
  • [23] Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer
    Krajewski, Wojciech
    Rodriguez Faba, Oscar
    Breda, Alberto
    Pisano, Francesca
    Poletajew, Slawomir
    Tukiendorf, Andrzej
    Zdrojowy, Romuald
    Kolodziej, Anna
    Palou, Juan
    WORLD JOURNAL OF UROLOGY, 2020, 38 (12) : 3177 - 3182
  • [24] Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: A success story with room for improvement
    Brandau, Sven
    Suttmann, Henrik
    BIOMEDICINE & PHARMACOTHERAPY, 2007, 61 (06) : 299 - 305
  • [25] Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer
    Wojciech Krajewski
    Oscar Rodríguez Faba
    Alberto Breda
    Francesca Pisano
    Sławomir Poletajew
    Andrzej Tukiendorf
    Romuald Zdrojowy
    Anna Kołodziej
    Juan Palou
    World Journal of Urology, 2020, 38 : 3177 - 3182
  • [26] Genomic Biomarkers and Underlying Mechanism of Benefit from BCG Immunotherapy in Non-Muscle Invasive Bladder Cancer
    Bastos, Diogo A.
    Mattedi, Romulo L.
    Barreiro, Rodrigo
    dos Santos, Filipe F.
    Buzatto, Vanessa
    Masotti, Cibele
    Souza, Jussara M.
    de Lima, Mariana Z. T.
    Friguglietti, Giulia W.
    Dzik, Carlos
    Jardim, Denis L. F.
    Coelho, Rafael
    Ribeiro Filho, Leopoldo A.
    Cordeiro, Mauricio D.
    Nahas, William C.
    de Mello, Evandro S.
    Chammas, Roger
    Reis, Luiz Fernando L.
    Bettoni, Fabiana
    Galante, Pedro A. F.
    Camargo, Anamaria A.
    BLADDER CANCER, 2020, 6 (02) : 171 - 186
  • [27] Predictors of response to BCG therapy in non-muscle invasive bladder cancer
    Radovanovic, Milan
    Petrovic, Milos
    Santric, Veljko
    Zubelic, Aleksa
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2022, 150 (1-2) : 113 - 116
  • [28] The relationship between BCG immunotherapy and oxidative stress parameters in patients with non-muscle invasive bladder cancer
    Singh, M. K.
    Singh, V.
    Kumar, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1639 - S1639
  • [29] CORRELATION BETWEEN BMI AND OUTCOMES IN PATIENTS TREATED WITH BCG IMMUNOTHERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Brooks, Nathan
    Matulay, Justin
    Xiao, Lianchun
    Li, Roger
    Kokorovic, Andrea
    Grossman, H. Barton
    Shen, Yu
    Gao, Jianjun
    Navai, Neema
    Dinney, Colin
    Kamat, Ashish
    JOURNAL OF UROLOGY, 2020, 203 : E1075 - E1075
  • [30] DISCONTINUANCE OF BCG IMMUNOTHERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER IS ASSOCIATED WITH LOWER PROGRESSION FREE SURVIVAL
    Minich, A.
    Sukonko, O. G.
    Krasny, S. A.
    Polyakov, S. L.
    Rolevich, A., I
    Vasilevich, V. Y.
    Mokhort, A. A.
    Zhegalik, A. G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 544 - 544
12345